BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26142252)

  • 1. Neuroligin 2 deletion alters inhibitory synapse function and anxiety-associated neuronal activation in the amygdala.
    Babaev O; Botta P; Meyer E; Müller C; Ehrenreich H; Brose N; Lüthi A; Krueger-Burg D
    Neuropharmacology; 2016 Jan; 100():56-65. PubMed ID: 26142252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroligin 2 is expressed in synapses established by cholinergic cells in the mouse brain.
    Takács VT; Freund TF; Nyiri G
    PLoS One; 2013; 8(9):e72450. PubMed ID: 24039767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABAergic deficits and schizophrenia-like behaviors in a mouse model carrying patient-derived neuroligin-2 R215H mutation.
    Jiang DY; Wu Z; Forsyth CT; Hu Y; Yee SP; Chen G
    Mol Brain; 2018 Jun; 11(1):31. PubMed ID: 29859117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASD/OCD-Linked Protocadherin-10 Regulates Synapse, But Not Axon, Development in the Amygdala and Contributes to Fear- and Anxiety-Related Behaviors.
    Hoshina N; Johnson-Venkatesh EM; Rally VR; Sant J; Hoshina M; Seiglie MP; Umemori H
    J Neurosci; 2022 May; 42(21):4250-4266. PubMed ID: 35504727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroligin-2 shapes individual slow waves during slow-wave sleep and the response to sleep deprivation in mice.
    Leduc T; El Alami H; Bougadir K; Bélanger-Nelson E; Mongrain V
    Mol Autism; 2024 Apr; 15(1):13. PubMed ID: 38570872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition in the amygdala anxiety circuitry.
    Babaev O; Piletti Chatain C; Krueger-Burg D
    Exp Mol Med; 2018 Apr; 50(4):1-16. PubMed ID: 29628509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial activation in the lateral amygdala promotes anxiety-like behaviors in mice with chronic moderate noise exposure.
    Peng X; Mao Y; Liu Y; Dai Q; Tai Y; Luo B; Liang Y; Guan R; Zhou W; Chen L; Zhang Z; Shen G; Wang H
    CNS Neurosci Ther; 2024 Mar; 30(3):e14674. PubMed ID: 38468130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional characterization of the IgSF21-neurexin2α complex and its related signaling pathways in the regulation of inhibitory synapse organization.
    Chofflet N; Naito Y; Pastore AJ; Padmanabhan N; Nguyen PT; Poitras C; Feller B; Yi N; Van Prooijen J; Khaled H; Coulombe B; Clapcote SJ; Bourgault S; Siddiqui TJ; Rudenko G; Takahashi H
    Front Mol Neurosci; 2024; 17():1371145. PubMed ID: 38571813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoding transcriptomic signatures of cysteine string protein alpha-mediated synapse maintenance.
    Wang N; Zhu B; Allnutt MA; Grijalva RM; Zhao H; Chandra SS
    Proc Natl Acad Sci U S A; 2024 Jun; 121(24):e2320064121. PubMed ID: 38833477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding transcriptomic signatures of Cysteine String Protein alpha-mediated synapse maintenance.
    Wang N; Zhu B; Allnutt MA; Grijalva RM; Zhao H; Chandra SS
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction to Supporting Information for Lee et al., MDGAs interact selectively with neuroligin-2 but not other neuroligins to regulate inhibitory synapse development.
    Proc Natl Acad Sci U S A; 2024 Jun; 121(26):e2410442121. PubMed ID: 38885391
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulating anxiety with extrasynaptic inhibition.
    Botta P; Demmou L; Kasugai Y; Markovic M; Xu C; Fadok JP; Lu T; Poe MM; Xu L; Cook JM; Rudolph U; Sah P; Ferraguti F; Lüthi A
    Nat Neurosci; 2015 Oct; 18(10):1493-500. PubMed ID: 26322928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroligin-2 and the tightrope of excitation/inhibition balance in the prefrontal cortex.
    Durieux AM; Horder J; Petrinovic MM
    J Neurophysiol; 2016 Jan; 115(1):5-7. PubMed ID: 26224778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique versus Redundant Functions of Neuroligin Genes in Shaping Excitatory and Inhibitory Synapse Properties.
    Chanda S; Hale WD; Zhang B; Wernig M; Südhof TC
    J Neurosci; 2017 Jul; 37(29):6816-6836. PubMed ID: 28607166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism.
    Hammer M; Krueger-Burg D; Tuffy LP; Cooper BH; Taschenberger H; Goswami SP; Ehrenreich H; Jonas P; Varoqueaux F; Rhee JS; Brose N
    Cell Rep; 2015 Oct; 13(3):516-523. PubMed ID: 26456829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroligins Sculpt Cerebellar Purkinje-Cell Circuits by Differential Control of Distinct Classes of Synapses.
    Zhang B; Chen LY; Liu X; Maxeiner S; Lee SJ; Gokce O; Südhof TC
    Neuron; 2015 Aug; 87(4):781-96. PubMed ID: 26291161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cellular and molecular landscape of neuroligins.
    Bemben MA; Shipman SL; Nicoll RA; Roche KW
    Trends Neurosci; 2015 Aug; 38(8):496-505. PubMed ID: 26209464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Cell mRNA Profiling Reveals Cell-Type-Specific Expression of Neurexin Isoforms.
    Fuccillo MV; Földy C; Gökce Ö; Rothwell PE; Sun GL; Malenka RC; Südhof TC
    Neuron; 2015 Jul; 87(2):326-40. PubMed ID: 26182417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroligin-2 Expression in the Prefrontal Cortex is Involved in Attention Deficits Induced by Peripubertal Stress.
    Tzanoulinou S; García-Mompó C; Riccio O; Grosse J; Zanoletti O; Dedousis P; Nacher J; Sandi C
    Neuropsychopharmacology; 2016 Feb; 41(3):751-61. PubMed ID: 26152839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity.
    Parente DJ; Garriga C; Baskin B; Douglas G; Cho MT; Araujo GC; Shinawi M
    Am J Med Genet A; 2017 Jan; 173(1):213-216. PubMed ID: 27865048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.